Exchange: NASDAQ·Updated 06:05 PM EDT

AZTA News

News
all
press releases
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTAPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5, 2026 /PRNewswire...
PR Newswire
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTAPR NewswireNEW YORK, Oct. 5, 2026NEW YORK, Oct. 5, 2026 /PRNewswire...
PR Newswire
More News
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action Investigation - AZTA
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Azenta, Inc. (NASDAQ: AZTA) resulting from allegations that Azenta may have issued materially misleading business information to the investing public.So...
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTAPR NewswireNEW YORK, Sept. 24, 2026 NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTAPR NewswireNEW YORK, Sept. 17, 2026 NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA PR Newswire NEW YORK, Sept. 10, 2026 NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems PR Newswire BURLINGTON, Mass., Sept. 4, 2026 BURLINGTON, Mass., Sept. 4, 2026 /PRNewswire/ -- Azenta, Inc...
PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA PR Newswire NEW YORK, Aug. 27, 2026 NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is...
PR Newswire
Azenta Names Martin Madaus Interim CEO As John Marotta Resigns
(RTTNews) - Azenta, Inc. (AZTA), a provider of life sciences solutions said on Monday that board member Martin Madaus has been appointed as Interim President and Chief Executive Officer, following the resignation of John Marotta as an Executive Officer and Director...
Nasdaq News: Markets
AZENTA ANNOUNCES LEADERSHIP TRANSITION
AZENTA ANNOUNCES LEADERSHIP TRANSITION AZENTA ANNOUNCES LEADERSHIP TRANSITION PR Newswire BURLINGTON, Mass., Aug. 24, 2026 Current Director Dr. Martin Madaus Appointed Interim CEOCompany Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue GuidanceBURLINGTON, Mass., Aug. 24, 2026...
PR Newswire
Life Science Funding Weakness Hit Azenta's (AZTA) Outlook
Life Science Funding Weakness Hit Azenta's (AZTA) Outlook...
Yahoo! Finance: News

Advertisement|Remove ads.